Two Sigma Investments’s QIAGEN NV QGENF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-720,811
Closed -$20.2M 3618
2016
Q4
$20.2M Sell
720,811
-18,660
-3% -$523K 0.08% 307
2016
Q3
$20.3M Buy
739,471
+467,992
+172% +$12.8M 0.07% 301
2016
Q2
$5.92M Sell
271,479
-517,087
-66% -$11.3M 0.03% 703
2016
Q1
$17.6M Buy
788,566
+766,436
+3,463% +$17.1M 0.08% 286
2015
Q4
$612K Sell
22,130
-39,453
-64% -$1.09M ﹤0.01% 1844
2015
Q3
$1.59M Sell
61,583
-65,354
-51% -$1.69M 0.01% 946
2015
Q2
$3.15M Sell
126,937
-3,463
-3% -$85.9K 0.01% 944
2015
Q1
$3.29M Buy
+130,400
New +$3.29M 0.02% 916
2014
Q1
Sell
-278,982
Closed -$6.64M 2596
2013
Q4
$6.64M Buy
+278,982
New +$6.64M 0.04% 544

Other funds holding QGENF

Two Sigma Investments's QGENF Position: Q1 2017 in Review

Two Sigma Investments sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 720,811 shares — an estimated $20.2M sold.

Two Sigma Investments first reported a position in QGENF in Q4 2013 and held it in 9 quarters. The position peaked at $20.3M in Q3 2016. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Two Sigma Investments reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Two Sigma Investments sold 720,811 QIAGEN NV shares in Q1 2017, an estimated $20.2M.
  • Two Sigma Investments first reported a position in QIAGEN NV in Q4 2013 and held it in 9 quarters.
  • Two Sigma Investments's QIAGEN NV position peaked at $20.3M in Q3 2016.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Two Sigma Investments's 13F filing for Q1 2017, filed 15 May 2017.